Ugur M, Baysal M, Umit E
J Clin Med. 2024; 13(18).
PMID: 39336893
PMC: 11432169.
DOI: 10.3390/jcm13185404.
Green A, Shen Y, Nelson A, Sarode R, Ibrahim I, Cao J
Ann Hematol. 2022; 101(12):2627-2631.
PMID: 36194257
PMC: 9530414.
DOI: 10.1007/s00277-022-04991-9.
Singh K, Zubair A, Prindle A, Nadeem A, Khan G
Endosc Int Open. 2019; 7(2):E282-E289.
PMID: 30705963
PMC: 6353713.
DOI: 10.1055/a-0799-9820.
McFarlane M, OFlynn L, Ventre R, Disney B
Frontline Gastroenterol. 2018; 9(2):98-104.
PMID: 29588836
PMC: 5868454.
DOI: 10.1136/flgastro-2017-100870.
Ricci K
Semin Intervent Radiol. 2017; 34(3):239-249.
PMID: 28955113
PMC: 5615390.
DOI: 10.1055/s-0037-1604297.
Bleeding recurrence in patients with gastrointestinal vascular malformation after thalidomide.
Chen H, Fu S, Feng N, Chen H, Gao Y, Zhao Y
Medicine (Baltimore). 2016; 95(33):e4606.
PMID: 27537596
PMC: 5370822.
DOI: 10.1097/MD.0000000000004606.
Anti-angiogenic therapeutic strategies in hereditary hemorrhagic telangiectasia.
Ardelean D, Letarte M
Front Genet. 2015; 6:35.
PMID: 25717337
PMC: 4324154.
DOI: 10.3389/fgene.2015.00035.
Optimal management of hereditary hemorrhagic telangiectasia.
Garg N, Khunger M, Gupta A, Kumar N
J Blood Med. 2014; 5:191-206.
PMID: 25342923
PMC: 4206399.
DOI: 10.2147/JBM.S45295.
Endoglin in liver fibrogenesis: Bridging basic science and clinical practice.
Meurer S, Alsamman M, Scholten D, Weiskirchen R
World J Biol Chem. 2014; 5(2):180-203.
PMID: 24921008
PMC: 4050112.
DOI: 10.4331/wjbc.v5.i2.180.
Brain arteriovenous malformation modeling, pathogenesis, and novel therapeutic targets.
Chen W, Choi E, McDougall C, Su H
Transl Stroke Res. 2014; 5(3):316-29.
PMID: 24723256
PMC: 4081044.
DOI: 10.1007/s12975-014-0343-0.
Endoglin: a critical mediator of cardiovascular health.
Kapur N, Morine K, Letarte M
Vasc Health Risk Manag. 2013; 9:195-206.
PMID: 23662065
PMC: 3647444.
DOI: 10.2147/VHRM.S29144.
Successful treatment of bleeding gastro-intestinal angiodysplasia in hereditary haemorrhagic telangiectasia with thalidomide.
Alam M, Sami S, Babu S
BMJ Case Rep. 2012; 2011.
PMID: 22674103
PMC: 3214210.
DOI: 10.1136/bcr.08.2011.4585.
Hereditary haemorrhagic telangiectasia: From symptomatic management to pathogenesis based treatment.
Fernandez-Fernandez F
Eur J Hum Genet. 2009; 18(4):404.
PMID: 19888298
PMC: 2987242.
DOI: 10.1038/ejhg.2009.188.
